Sixty Years of Community Health Centers - An Anniversary at a Crossroads [0.03%]
六十载风雨兼程 全球卫生中心联盟甲子庆生路在何方？
Alexander E Jacobs
Alexander E Jacobs
Mazen Noureddin,Mary E Rinella,Naga P Chalasani et al.
Mazen Noureddin et al.
Background: In phase 2 trials involving patients with stage 2 or 3 fibrosis caused by metabolic dysfunction-associated steatohepatitis (MASH), efruxifermin, a bivalent fibroblast growth factor 21 (FGF21) analogue, reduced...
In-Suk Bae,Yung Ki Park
In-Suk Bae
The Last Dose [0.03%]
最后的剂量
David N Korones
David N Korones
Death by a Thousand Cuts - The Crushing Weight of Nonclinical Demands in Primary Care [0.03%]
千刀万剐：初级保健中非临床需求的沉重压力
Bruce E Landon,Sara B Fazio,Jennifer L Cluett et al.
Bruce E Landon et al.
Alessio Fasano
Alessio Fasano
The Physiology of Hunger [0.03%]
饥饿的生理学
Jens Lund,Thorkild I A Sørensen,Mark I Friedman
Jens Lund
The Physiology of Hunger [0.03%]
饥饿的生理学
Sergio Loss,Joel Stefani,Luciana Viana
Sergio Loss
The Physiology of Hunger [0.03%]
饥饿的生理学
Hakim Rahmoune,Nada Boutrid
Hakim Rahmoune
Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A. Reply [0.03%]
针对遗传性血友病A的基因治疗研究及回复式通信答复文章：采用CD34+造血细胞进行慢病毒基因治疗
Alok Srivastava,Trent Spencer
Alok Srivastava